ARYA Sciences Acquisition Corp V, trading under the ticker ARYE, is a blank-check company organized as part of the ARYA Sciences series sponsored by Perceptive Advisors, a healthcare-focused investment firm. The company filed its S-1 registration statement with the SEC on June 24, 2021, targeting the life sciences and biotechnology sector in line with the broader ARYA Sciences franchise, which has consistently pursued targets in biopharma, medical technology, and related healthcare disciplines. Perceptive Advisors has operated multiple SPAC vehicles under the ARYA Sciences name, reflecting sustained institutional interest in life sciences deal-making through the SPAC structure. For full pipeline details, current status, deal history, and comparable SPAC analytics, sign up for a SpacDesk account at spacdesk.com.